Evaluating External Validity of Oncology Biosimilar Safety Studies

JAMA Netw Open. 2023 Apr 3;6(4):e235776. doi: 10.1001/jamanetworkopen.2023.5776.

Authors

Gregory S Calip^{1

2}, Ivy P Altomare¹, Jenny S Guadamuz^{1

3}

Affiliations

¹ Flatiron Health, New York, New York.
² Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois Chicago, Chicago.
³ School of Pharmacy, Program on Medicines and Public Health, University of Southern California, Los Angeles.

PMID: 37022693
DOI: 10.1001/jamanetworkopen.2023.5776

No abstract available

Publication types

Comment

MeSH terms

Biosimilar Pharmaceuticals* / adverse effects
Humans
Medical Oncology
Neoplasms* / drug therapy

Substances

Biosimilar Pharmaceuticals